Lexpos News

Update 04/02/2025 – The NHS Business Services Authority (NHSBSA) has notified Community Pharmacy England that essential maintenance took place on the Manage Your Service (MYS) Pharmacy portal on Saturday 18 January 2025 as scheduled and as a result, there has been a change to the maintenance planned for the remaining two dates. Maintenance work will now [...]

The post Update: Planned MYS downtime due to essential maintenance appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/01/2025) announced the following initial list of price concessions for January 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £3.80 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% [...]

The post January 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

This is the eighth of a series of articles to tackle some of the misconceptions around Pharmacy First. The articles will cover a variety of aspects of Pharmacy First and aims to myth bust, to increase understanding of the service. It is fine to always select ‘other’ and free type the outcome of the consultation [...]

The post Pharmacy First myth busting series (#8) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Xylocaine® (lidocaine) 10mg spray MSN/2025/003 Tier 2 medium impact Date of issue: 14th January 2025 Xylocaine® (lidocaine) 10mg spray is out of stock until mid-February 2025. Lidocaine 5% / Phenylephrine 0.5% spray remains available and can support an increase in demand. [...]

The post Medicine Supply Notification: Xylocaine® (lidocaine) 10mg spray appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/02 Date issued: 13 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) [...]

The post MHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.